Figure 2.
Kaplan–Meier estimator plot of all-cause mortality for paclitaxel DCBs vs. second-generation DESs for de novo LMS disease. The number at risk is represented at the bottom. This shows no significant difference between the groups.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.